CMPS insider transaction filings
COMPASS Pathways plc — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-05. Screen CMPS transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 1 Form 4 filing. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Nath Kabir — Chief Executive Officer, Director | 1 | — | — | 1 |
Recent Form 4 filings — COMPASS Pathways plc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-05 | 4 | Nath Kabir — Chief Executive Officer, Director | Tax withholding (F): 5,962 @ $11.25 | EDGAR |
| 2026-05-29 | 4 | McQuade Robert — Director | Grant/award (A): 21,110 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Tregoning Kathleen — Director | Grant/award (A): 41,119 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Karydas Daphne — Director | Grant/award (A): 21,110 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Gover Justin D. — Director | Grant/award (A): 21,110 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Norton David Y — Director | Grant/award (A): 21,110 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Riley Wayne Joseph — Director | Grant/award (A): 21,110 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | SANTINI GINO — Director | Grant/award (A): 30,158 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | JONAS JEFFREY M — Director | Grant/award (A): 21,110 (derivative) @ $0 | EDGAR |
| 2026-03-27 | 4 | Nath Kabir — Chief Executive Officer, Director | Grant/award (A): 175,000 @ $0 · Grant/award (A): 367,815 (derivative) @ $0 | EDGAR |
| 2026-03-27 | 4 | Goodwin Guy — Chief Medical Officer | Grant/award (A): 55,000 (derivative) @ $0 · Grant/award (A): 115,600 (derivative) @ $0 | EDGAR |
| 2026-03-27 | 4 | Loxam Teri — Chief Financial Officer | Grant/award (A): 75,000 @ $0 · Grant/award (A): 157,635 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | Nath Kabir — Chief Executive Officer, Director | Tax withholding (F): 13,131 @ $6.89 | EDGAR |
| 2026-03-13 | 4 | Loxam Teri — Chief Financial Officer | Tax withholding (F): 1,781 @ $6.89 | EDGAR |
| 2026-03-03 | 4 | Loxam Teri — Chief Financial Officer | Tax withholding (F): 4,467 @ $7.02 | EDGAR |
| 2026-02-03 | 4 | Nath Kabir — Chief Executive Officer, Director | Tax withholding (F): 16,181 @ $6.61 | EDGAR |
| 2025-10-31 | 4 | JONAS JEFFREY M — Director | Grant/award (A): 52,000 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | Nath Kabir — Chief Executive Officer, Director | Tax withholding (F): 6,366 @ $4.34 | EDGAR |
| 2025-07-30 | 4 | Gover Justin D. — Director | Grant/award (A): 52,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Karydas Daphne — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | McQuade Robert — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Lonngren Thomas — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Jenkins Annalisa — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Norton David Y — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Riley Wayne Joseph — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | McGoldrick Linda — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | SANTINI GINO — Director | Grant/award (A): 39,000 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Goodwin Guy — Chief Medical Officer | Grant/award (A): 32,000 (derivative) @ $0 · Grant/award (A): 63,000 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Loxam Teri — Chief Financial Officer | Grant/award (A): 25,000 @ $0 · Grant/award (A): 76,000 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Nath Kabir — Chief Executive Officer, Director | Grant/award (A): 92,000 @ $0 · Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Loxam Teri — Chief Financial Officer | Tax withholding (F): 4,468 @ $3.67 | EDGAR |
| 2025-02-05 | 4 | Nath Kabir — Chief Executive Officer, Director | Tax withholding (F): 15,516 @ $4.31 | EDGAR |
| 2024-10-25 | 4 | Malievskaia Ekaterina — 10% owner | Sale (S): 776,565 · Sale (S): 776,565 | EDGAR |
| 2024-10-25 | 4 | Goldsmith George Jay — 10% owner | Sale (S): 776,565 · Sale (S): 776,565 | EDGAR |
| 2024-09-27 | 4 | ATAI Life Sciences N.V. — 10% owner ATAI Life Sciences AG — 10% owner | Sale (S): 2,660,000 @ $6.05 | EDGAR |
| 2024-09-04 | 4 | SANTINI GINO — Director | Grant/award (A): 52,000 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | Nath Kabir — Chief Executive Officer, Director | Tax withholding (F): 7,064 @ $6.88 | EDGAR |
| 2024-08-05 | 4 | Jenkins Annalisa — Director | Tax withholding (F): 161 @ $6.88 | EDGAR |
| 2024-05-22 | 4 | Malievskaia Ekaterina — 10% owner | Sale (S): 6,704 @ $7.89 · Sale (S): 6,703 @ $7.89 · Sale (S): 8,900 @ $7.91 · Sale (S): 8,900 @ $7.91 | EDGAR |
| 2024-05-22 | 4 | Goldsmith George Jay — 10% owner | Sale (S): 6,703 @ $7.89 · Sale (S): 6,704 @ $7.89 · Sale (S): 8,900 @ $7.91 · Sale (S): 8,900 @ $7.91 | EDGAR |
| 2024-05-13 | 4 | Lonngren Thomas — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | McQuade Robert — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | Karydas Daphne — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | Jenkins Annalisa — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | Norton David Y — Director | Grant/award (A): 39,000 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | Riley Wayne Joseph — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | McGoldrick Linda — Director | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | Goldsmith George Jay — 10% owner | Sale (S): 9,621 @ $8.29 · Sale (S): 9,622 @ $8.29 · Sale (S): 18,762 @ $8.82 · Sale (S): 18,761 @ $8.82 | EDGAR |
| 2024-05-06 | 4 | Malievskaia Ekaterina — 10% owner | Sale (S): 9,622 @ $8.29 · Sale (S): 9,621 @ $8.29 · Sale (S): 18,761 @ $8.82 · Sale (S): 18,762 @ $8.82 | EDGAR |
| 2024-05-03 | 4 | Jenkins Annalisa — Director | Tax withholding (F): 211 @ $8.48 | EDGAR |
Recent 8-K events — COMPASS Pathways plc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-28 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-29 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CMPS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →